Emerging Implant Technologies Receives FDA Clearance for Interbody Devices

Emerging Implant Technologies (EIT) received FDA 510(k) clearance for 3D-printed spinal interbody devices to address anterior, transforaminal and posterior lumbar interbody fusion and cervical procedures.

The implants are manufactured from EIT Cellular Titanium® that yields a porosity of 80% and is designed to address clinical shortcomings...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us